ARE הכנסה נקייה של החברה Alexandria

The net final profit of Alexandria (ARE) as shown in the GURU.Markets chart demonstrates financial resilience, where -1.42 captures the magnitude of this parameter. Growth is driven by a shortage of specialized biotech campuses and long-term deals with pharmaceutical behemoths. Assets are protected from sanctions, although the severance of scientific ties could reduce demand. Niche concentration is offset by the premium quality of the world's largest tenants.

Net income reflects the issuer's final financial result after deducting all operating and tax expenses. The stability of this metric confirms the viability of the business model amid the Fed's tight monetary policy. By analyzing the company's profit margins, an investor can assess the sustainability of the long-term trend and the risks of buying at peaks. For Alexandria (ARE), this indicator depends directly on the management efficiency of specialized properties. Profit growth here is driven by stable rental streams from the high-tech pharmaceutical and biotechnology sectors.